Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity

被引:180
作者
Mashili, Fredirick L. [1 ]
Austin, Reginald L. [2 ]
Deshmukh, Atul S. [2 ]
Fritz, Tomas [3 ]
Caidahl, Kenneth [2 ]
Bergdahl, Katrin [1 ]
Zierath, Juleen R. [2 ]
Chibalin, Alexander V. [2 ]
Moller, David E. [4 ]
Kharitonenkov, Alexei [4 ]
Krook, Anna [1 ,2 ]
机构
[1] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden
[2] Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden
[3] Karolinska Inst, Ctr Family Med, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden
[4] Lilly Res Labs, Indianapolis, IN USA
基金
瑞典研究理事会; 欧洲研究理事会;
关键词
human skeletal muscle; FGF21; BMI; glucose uptake; FIBROBLAST GROWTH FACTOR-21; LIPID-METABOLISM; INSULIN ACTION; BETA-KLOTHO; EXPRESSION; GLUT4; CELL; SPECIFICITY; REGULATOR; FGF-21;
D O I
10.1002/dmrr.1177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Fibroblast growth factor (FGF) 21, a novel member of the FGF family, plays a role in a variety of endocrine functions, including regulation of glucose and lipid metabolism. The role of FGF21 in skeletal muscle is currently not known. Methods Serum levels and skeletal muscle mRNA of FGF21 were determined in normal glucose tolerant (n = 40) and type 2 diabetic (T2D; n = 40) subjects. We determined whether FGF21 has direct effects on glucose metabolism in cultured myotubes (n = 8) and extensor digitorum longus skeletal muscle. Results Serum FGF21 levels increased 20% in T2D versus normal glucose tolerant subjects (p < 0.05), whereas skeletal muscle mRNA expression was unaltered. Fasting insulin, homeostatic model assessment of insulin resistance (HOMA-IR), waist circumference, and body mass index (BMI) significantly correlated with serum FGF21 levels in T2D (p < 0.01), but not in normal glucose tolerant subjects. Serum FGF21 concentrations were greater in T2D patients in the highest tertile of fasting insulin (p < 0.05) and BMI (p < 0.05). Stepwise regression analysis identified BMI as the strongest independent variable correlating with FGF21. FGF21 exposure increased basal and insulin-stimulated glucose uptake in human myotubes, coincident with increased glucose transporter 1 mRNA, and enhanced glucose transporter 1 abundance at the plasma membrane. In isolated extensor digitorum longus muscle, FGF21 potentiated insulin-stimulated glucose transport, without altering phosphorylation of Akt or AMP-activated protein kinase. Conclusions Plasma FGF21 is increased in T2D patients, and positively correlated with fasting insulin and BMI. However, FGF21 has direct effects in enhancing skeletal muscle glucose uptake, providing additional points of regulation that may contribute to the beneficial effects of FGF21 on glucose homeostasis. Whether increased plasma FGF21 in T2D is a compensatory mechanism to increase glucose metabolism remains to be determined. Copyright (c) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:286 / 297
页数:12
相关论文
共 55 条
[1]   Human skeletal muscle cell differentiation is associated with changes in myogenic markers and enhanced insulin-mediated MAPK and PKB phosphorylation [J].
Al-Khalili, L ;
Krämer, D ;
Wretenberg, P ;
Krook, A .
ACTA PHYSIOLOGICA SCANDINAVICA, 2004, 180 (04) :395-403
[2]   Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content [J].
Al-Khalili, L ;
Chibalin, AV ;
Kannisto, K ;
Zhang, BB ;
Permert, J ;
Holman, GD ;
Ehrenborg, E ;
Ding, VDH ;
Zierath, JR ;
Krook, A .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (05) :991-998
[3]   Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle [J].
Al-Khalili, Lubna ;
Bouzakri, Karim ;
Glund, Stephan ;
Lonnqvist, Fredrik ;
Koistinen, Heikki A. ;
Krook, Anna .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (12) :3364-3375
[4]   FGF21 attenuates lipolysis in human adipocytes -: A possible link to improved insulin sensitivity [J].
Arner, Peter ;
Pettersson, Amanda ;
Mitchell, Pamela J. ;
Dunbar, James D. ;
Kharitonenkov, Alexei ;
Ryden, Mikael .
FEBS LETTERS, 2008, 582 (12) :1725-1730
[5]   Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis [J].
Badman, Michael K. ;
Koester, Anja ;
Flier, Jeffrey S. ;
Kharitonenkov, Alexei ;
Maratos-Flier, Eleftheria .
ENDOCRINOLOGY, 2009, 150 (11) :4931-4940
[6]   The 5′-AMP-activated protein kinase γ3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle [J].
Barnes, BR ;
Marklund, S ;
Steiler, TL ;
Walter, M ;
Hjälm, G ;
Amarger, V ;
Mahlapuu, M ;
Leng, Y ;
Johansson, C ;
Galuska, D ;
Lindgren, K ;
Åbrink, M ;
Stapleton, D ;
Zierath, JR ;
Andersson, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) :38441-38447
[7]   Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity [J].
Berglund, Eric D. ;
Li, Candice Y. ;
Bina, Holly A. ;
Lynes, Sara E. ;
Michael, M. Dodson ;
Shanafelt, Armen B. ;
Kharitonenkov, Alexei ;
Wasserman, David H. .
ENDOCRINOLOGY, 2009, 150 (09) :4084-4093
[8]   Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man [J].
Christodoulides, Constantinos ;
Dyson, Pamela ;
Sprecher, Dennis ;
Tsintzas, Kostas ;
Karpe, Fredrik .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09) :3594-3601
[9]   Fibroblast Growth Factor 21 Corrects Obesity in Mice [J].
Coskun, Tamer ;
Bina, Holly A. ;
Schneider, Michael A. ;
Dunbar, James D. ;
Hu, Charlie C. ;
Chen, Yanyun ;
Moller, David E. ;
Kharitonenkov, Alexei .
ENDOCRINOLOGY, 2008, 149 (12) :6018-6027
[10]   EFFECTS OF INSULIN ON PERIPHERAL AND SPLANCHNIC GLUCOSE-METABOLISM IN NONINSULIN-DEPENDENT (TYPE-II) DIABETES-MELLITUS [J].
DEFRONZO, RA ;
GUNNARSSON, R ;
BJORKMAN, O ;
OLSSON, M ;
WAHREN, J .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (01) :149-155